InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2024-05-02 00:00:00 ET · period of report 2024-05-01 · accession 0001477449-24-000105 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-02 2024-05-02 TDOC Raman-Tangella Vidya Chief MEDICAL Off S - Sale+OE $12.69 -3,691 29.2K -11% -$46.8K
D 2024-05-02 2024-05-01 TDOC Raman-Tangella Vidya Chief MEDICAL Off M - OptEx — +10.2K 32.9K +45% —
D 2024-05-02 2024-05-01 TDOC Raman-Tangella Vidya Chief MEDICAL Off M - OptEx $0.00 -10.2K 41.0K -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-02 S D 3,691 $12.69 29,160 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
2 Common Common Stock 2024-05-01 M A 10,244 — 32,851 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
3 Derivative Restricted Stock Units 2024-05-01 M D 10,244 $0.00 40,976 D — · — to — 10,244 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On May 1, 2022, the reporting person was granted 122,927 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.